Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study. Jindal T, Jiang CY, Alhalabi O, Davidsohn M, et al. Urol Oncol 2026;44:65.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jindal T, Jiang CY, Alhalabi O, Davidsohn M, et al. Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study. Urol Oncol 2026;44:65.
PMID: 41152111